Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Eli Lilly Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (76)
Cancellation by sponsor (55)
Australian Public Assessment Report (AusPAR) (19)
Prescription medicine registration (16)
Designation or determination (4)
Prescription medicine decision summary (3)
Prescription medicine evaluation (3)

Date

2024 (23)
2023 (22)
2022 (15)
2021 (10)
2020 (4)
2019 (34)
2018 (14)
2017 (1)
2016 (2)
2015 (7)
2014 (2)
2013 (4)
2012 (1)
2011 (2)
2010 (1)
2008 (4)
2007 (3)
2006 (1)
2004 (7)
2003 (1)
2002 (2)
1999 (5)
1998 (1)
1996 (2)
1993 (1)
1992 (4)
1991 (3)

Results for "[search-keyword]"

Search

Sponsor content

176 result(s) found, displaying 121 to 130

Notice for olaratumab (rmc) (Eli Lilly Australia Pty Ltd)

12 April 2018

Designation or determination

Provisional approval
Eli Lilly Australia Pty Limited - Injector, medication/vaccine, needle Cancelled under Section 41GL(d) of the Act

23 February 2018

Cancellation by sponsor

Requested by Eli Lilly Australia Pty Ltd
Eli Lilly Australia Pty Limited - Insuin injection kit - Injector, medication/vaccine, needle Cancelled under Section 41GL(d) of the Act

23 February 2018

Cancellation by sponsor

Requested by Eli Lilly Australia Pty Ltd
Eli Lilly Australia Pty Limited - Injector, medication/vaccine, needle Cancelled under Section 41GL(d) of the Act

23 February 2018

Cancellation by sponsor

Requested by Eli Lilly Australia Pty Ltd
Eli Lilly Australia Pty Limited - Cover Cancelled under Section 41GL(d) of the Act

23 February 2018

Cancellation by sponsor

Requested by Eli Lilly Australia Pty Ltd
Notice for olaratumab (rmc) (Eli Lilly Australia Pty Ltd)

9 February 2018

Designation or determination

Orphan drug
OLUMIANT (Eli Lilly Australia Pty Ltd)

19 January 2018

Prescription medicine registration

Active ingredients: baricitinib.
TRULICITY dulaglutide (rch) 1.5 mg/0.5 mL solution for injection prefilled pen (217965)

19 January 2015

ARTG

Australian Register of Therapeutic Goods (ARTG) information for TRULICITY dulaglutide (rch) 1.5 mg/0.5 mL solution for injection prefilled pen.
BASAGLAR KwikPen insulin glargine (rbe) 100 IU/mL solution for injection cartridge (215552)

21 November 2014

ARTG

Australian Register of Therapeutic Goods (ARTG) information for BASAGLAR KwikPen insulin glargine (rbe) 100 IU/mL solution for injection cartridge.
BASAGLAR insulin glargine (rbe) 100 IU/mL solution for injection cartridge (215551)

21 November 2014

ARTG

Australian Register of Therapeutic Goods (ARTG) information for BASAGLAR insulin glargine (rbe) 100 IU/mL solution for injection cartridge.

Pages

First page
Previous page
…
Page 9
Page 10
Page 11
Page 12
Current page 13
Page 14
Page 15
Page 16
Page 17
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.